Financials
- Market Capitalization 1.78 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-63.19
Fiyat/satışlar oranı
15.2
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2065 | VIR Vir Biotechnology, Inc. - Common Stock | 10.78 USD | -0.46% | +10.00% | +23.34% | +80.27% | 1.82 B USD | ||
| 2070 | INBX Inhibrx Biosciences, Inc. - Common Stock | 123.41 USD | -0.42% | +17.53% | +50.76% | +53.15% | 1.82 B USD | ||
| 2076 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.54 USD | -2.56% | +0.64% | +18.41% | -8.60% | 1.76 B USD | ||
| 2083 | FTRE Fortrea Holdings Inc. - Common Stock | 18.20 USD | -3.24% | +0.61% | -5.41% | +88.80% | 1.73 B USD |